Table 2:

Details of patients with dark-signal lesions

Case No.Age (yr)/SexAneurysmLesionAnticoagulant or Antiplatelet Maintenanceb
LocationSize (mm)LocationSize (mm)TOF-MRAa
144/FRt ICA6Rt parietal11NoAntiplatelet
257/MAcomA4Lt temporal10YesNone
372/MLt ICA5Lt temporal10YesAntiplatelet
AcomA5
472/MAcomA5Rt frontal7NoAntiplatelet
560/FRt SCA5Rt midbrain8YesNone
Lt PCA3
668/FLt ICAc3Lt parietal11NoAntiplatelet
749/MLt ICA4Lt temporal9YesAntiplatelet
863/FRt ICA4Rt temporal9YesNone
952/FRt MCA4Rt temporal10YesAntiplatelet
Rt ICA4Rt CC10Yes
1019/FLt ICA15Rt frontal6YesAntiplatelet
Lt frontal5No
Lt frontal5No
1159/FRt ICA3Lt parietal8NoNone
1266/FAcomA3Lt frontal10NoAntiplatelet
1349/FRt ICA7Rt frontal5YesAntiplatelet
1439/FLt ICAc4Lt BG7YesAntiplatelet
Rt parietal7Yes
Rt parietal7No
1560/FRt MCA11Rt parietal8NoNone
1662/FRt SCAc8Rt occipital10YesAntiplatelet
1763/FRt ICA4Rt frontal6YesAntiplatelet
Lt ICA3
1871/MAcomA6Rt frontal5NoAntiplatelet
1954/FLt ICA4Lt CC5YesNone
2058/FRt MCA5Rt frontal7NoNone
  • Note:—Rt indicates right; Lt, left; PCA, posterior cerebral artery; CC, corpus callosum; SCA, superior cerebellar artery; BG, basal ganglia.

  • a Indicates whether the dark-signal lesion on SWI was covered in the source image of TOF-MRA.

  • b Indicates maintenance >1 month after coil embolization.

  • c Denotes ruptured aneurysm.